Skorpios Trust

Insider Reports History

Entity
Company
Location
195 Arch. Makarios III Ave., Neocleous House, Limassol, Cyprus
Signature
/s/ Androulla Papadopoulou, Authorized Signatory on behalf of Skorpios Trust
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Skorpios Trust:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. 10%+ Owner Common Stock 8.91M $125M $14.05 Sep 19, 2024 Indirect
Akero Therapeutics, Inc. Former 10% owner Common Stock 3.27M $2.01M $0.62 Dec 1, 2022 Indirect

Insider Reports Filed by Skorpios Trust

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STOK Stoke Therapeutics, Inc. Sep 19, 2024 1 -$27.2M 4 Sep 23, 2024 10%+ Owner
STOK Stoke Therapeutics, Inc. Apr 17, 2024 1 -$41.8M 4 Apr 18, 2024 10%+ Owner
AKRO Akero Therapeutics, Inc. Dec 1, 2022 1 -$71.2M 4 Dec 5, 2022 Former 10% owner
AKRO Akero Therapeutics, Inc. Jun 21, 2021 0 $0 3 Jun 30, 2021 10%+ Owner
STOK Stoke Therapeutics, Inc. Jun 21, 2021 0 $0 3 Jun 30, 2021 10%+ Owner